Shoulder Innovations, Inc. Reports Third Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Outlook
11/5/2026
Impact: 70
Healthcare
Shoulder Innovations reported third-quarter 2026 revenue of $16.2 million, up 38% year over year. Gross margin rose to 78.5% from 76.2%, and net loss narrowed to $7.0 million from $8.7 million. Research and development expenses increased 107% to $3.2 million, reflecting investment in new products including the InSet Neo robotic platform. The company raised its 2026 revenue outlook to $68 million–$70 million from $67 million–$69 million, implying annual growth of approximately 44%–48%.
AI summary, not financial advice
Share: